# Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

> **NCT06050434** · — · TERMINATED · sponsor: **Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest** · enrollment: 7 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06050434
- **Lead sponsor:** Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-31
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** The study was terminated prematurely due to slow recruitment after inclusion of 7 patients (of initially planned 100 patients).
- **Last updated:** 2025-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06050434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06050434, "Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT06050434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*